Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients

Bibliographic Details
Main Authors:	Gerold Thölking, Stefan Reuter
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Pharmacology
Subjects:	kidney metabolism C/D ratio tacrolimus transplantation renal
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.603345/full

Similar Items

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
by: Gerold Thölking, et al.
Published: (2021-07-01)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01)

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020-07-01)

The Impact of CYP3A5 Genotype on the Interaction Between Tacrolimus and Intravenous Nicardipine in Kidney Transplant Recipients
by: Hooper, David K.
Published: (2010)

A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
by: Gerold Thölking, et al.
Published: (2019-10-01)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01)

Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation
by: Katharina Schütte-Nütgen, et al.
Published: (2019-04-01)

Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
by: Chen L, et al.
Published: (2018-03-01)

Tacrolimus Dose Requirement in Iranian Kidney Transplant Recipients within the First Three Weeks after Transplantation
by: S Dashti-Khavidaki, et al.
Published: (2016-07-01)

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients
by: Yoshiharu Suzuki, et al.
Published: (2021-08-01)

Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)

CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)

Comparing the effect of immediate versus delayed initiation of tacrolimus on delayed graft function in Kidney transplant recipients: A randomized open-label clinical trial
by: Maryam Ghadimi, et al.
Published: (2018-01-01)

Effect of tacrolimus on the results of living related kidney donor transplantation
by: V A Goriaĭnov, et al.
Published: (2014-06-01)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011-01-01)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020-04-01)

Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients
by: Charat Thongprayoon, et al.
Published: (2020-07-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients
by: Salgado PC, et al.
Published: (2017-03-01)

A case report: acute pancreatitis associated with tacrolimus in kidney transplantation
by: Junnan Xu, et al.
Published: (2019-06-01)

Antihypertensive Treatment in Kidney Transplant Recipients—A Current Single Center Experience
by: Ulrich Jehn, et al.
Published: (2020-12-01)

Safety and effectiveness of everolimus compared with sirolimus and tacrolimus in preventing kidney transplantation rejection: a systematic review and meta-analysis
by: Morteza Arab Zozani, et al.
Published: (2015-08-01)

Basiliximab induction in living donor kidney transplant with tacrolimus-based triple immunosuppression
by: Shyam Bihari Bansal, et al.
Published: (2019-01-01)

Tacrolimus and diabetic ketoacidosis after kidney transplantation in a 15-year-old girl (Case Report)
by: Hadi Sorkhi, et al.
Published: (2016-09-01)

Early serum tacrolimus levels predict long-term chronic kidney disease after liver transplantation
by: Vanessa B. A. Brandão, et al.

Influence of CYP3A5 and ABCB1 polymorphism on tacrolimus drug dosing in South Indian renal allograft recipients
by: M Edwin Fernando, et al.
Published: (2019-01-01)

Conversion from Standard-Release Tacrolimus to MeltDose<sup>®</sup> Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
by: Johannes von Einsiedel, et al.
Published: (2020-06-01)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
by: Hideaki Kagaya, et al.
Published: (2018-03-01)

CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients
by: Paola Krall, et al.
Published: (2021-04-01)

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
by: Pere Fontova, et al.
Published: (2021-03-01)

Transplant Recipients Using Tacrolimus Had Higher Utilization of Healthcare Services Than Those Receiving Cyclosporine in Taiwan
by: Yi-Chang Lin, et al.
Published: (2019-09-01)

Haemochromatosis in a kidney transplant recipient: a case report
by: Izabela Zakrocka, et al.
Published: (2021-05-01)

HSD11B1 rs846908 polymorphisms and tacrolimus concentrations: quantum chemical analysis and implication in patients with renal transplantation
by: Beuy Joob, et al.
Published: (2017-01-01)

Efficacy and outcomes of CYP3A5 genotype-based tacrolimus dosing compared to conventional body weight-based dosing in living donor kidney transplant recipients
by: Edwin Fernando, M., et al.
Published: (2022)

Clinical experience of conversion from cyclosporine to tacrolimus prolonged-release in stabilized kidney transplant patients
by: Karel Krejci, et al.
Published: (2016-09-01)

Tacrolimus as a rare cause of pericardial effusion in a renal transplant recipient
by: Rohini Prashar, et al.
Published: (2017-01-01)

Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)

Conversion from Twice-Daily to Once-Daily Tacrolimus Improves Graft Function but has no Influence on Proteinuria in Renal Transplant Recipients
by: Basic-Jukic Nikolina, et al.
Published: (2016-12-01)

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
by: Effrosyni Mendrinou, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_84cfdliqil248jhpqjetjhlrvg